NCT06221111View on ClinicalTrials.gov

Comparison of Rimegepant and Placebo for Pain in IBS

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

June 3, 2025

Conditions

Irritable Bowel Syndrome

Interventions

DRUG

Rimegepant 75 MG [Nurtec]

placebo controlled trial

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Mayo Clinic

OTHER

NCT06221111 - Comparison of Rimegepant and Placebo for Pain in IBS | Biotech Hunter | Biotech Hunter